81 related articles for article (PubMed ID: 28470753)
1. pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.
Sato S; Yanagisawa T; Miki J; Hayashida Y; Okada Y; Iwatani K; Matsukawa A; Kimura T; Egawa S; Shimoda M; Takahashi H
Arch Pathol Lab Med; 2024 May; 148(5):573-580. PubMed ID: 37671794
[TBL] [Abstract][Full Text] [Related]
2. Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients.
Orsola A; Werner L; de Torres I; Martin-Doyle W; Raventos CX; Lozano F; Mullane SA; Leow JJ; Barletta JA; Bellmunt J; Morote J
Br J Cancer; 2015 Feb; 112(3):468-74. PubMed ID: 25535728
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive Papillary Urothelial Carcinoma of the Bladder: An Institutional Experience Focusing on Tumors With Borderline Features.
Oliver-Krasinski JM; Bidot S; Ingram JW; O'Toole KM; McKiernan JM; Tinsley M; Harik LR
Arch Pathol Lab Med; 2024 Feb; 148(2):223-229. PubMed ID: 37134243
[TBL] [Abstract][Full Text] [Related]
4. Detection of Muscularis propria Invasion in Urothelial Carcinoma Using Artificial Intelligence.
Fahoum I; Naamneh R; Silberberg K; Hagege R; Hershkovitz D
Technol Cancer Res Treat; 2024; 23():15330338241257479. PubMed ID: 38803309
[No Abstract] [Full Text] [Related]
5. CD47 expression in urothelial carcinoma and its correlation with histopathological findings.
Çoban G; Yıldız P; Şahin N; Ersöz C; Toprak A; Ünver N; Elagöz Ş
Indian J Cancer; 2023 Oct; 60(4):458-463. PubMed ID: 38078465
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection.
Yanagisawa T; Sato S; Hayashida Y; Okada Y; Matsukawa A; Iwatani K; Shimoda M; Takahashi H; Kimura T; Shariat SF; Miki J
Histopathology; 2024 Mar; ():. PubMed ID: 38477374
[TBL] [Abstract][Full Text] [Related]
7. Automated tumour budding quantification by machine learning augments TNM staging in muscle-invasive bladder cancer prognosis.
Brieu N; Gavriel CG; Nearchou IP; Harrison DJ; Schmidt G; Caie PD
Sci Rep; 2019 Mar; 9(1):5174. PubMed ID: 30914794
[TBL] [Abstract][Full Text] [Related]
8. Proteogenomics of different urothelial bladder cancer stages reveals distinct molecular features for papillary cancer and carcinoma in situ.
Yao Z; Xu N; Shang G; Wang H; Tao H; Wang Y; Qin Z; Tan S; Feng J; Zhu J; Ma F; Tian S; Zhang Q; Qu Y; Hou J; Guo J; Zhao J; Hou Y; Ding C
Nat Commun; 2023 Sep; 14(1):5670. PubMed ID: 37704624
[TBL] [Abstract][Full Text] [Related]
9. Pathological Extramural Venous Invasion in High-stage Urothelial Carcinoma of the Bladder has Shorter Locoregional Recurrence-free Survival.
Mohamed KS; Desai K; El-Habashy D; Liu S
Int J Surg Pathol; 2024 May; ():10668969241253209. PubMed ID: 38803228
[TBL] [Abstract][Full Text] [Related]
10. Reconstructing disease dynamics for mechanistic insights and clinical benefit.
Frishberg A; Milman N; Alpert A; Spitzer H; Asani B; Schiefelbein JB; Bakin E; Regev-Berman K; Priglinger SG; Schultze JL; Theis FJ; Shen-Orr SS
Nat Commun; 2023 Oct; 14(1):6840. PubMed ID: 37891175
[TBL] [Abstract][Full Text] [Related]
11. Stromal and Epithelial Architectural Alterations Mimicking Invasion (Pseudoinvasion) in Noninvasive Papillary Urothelial Carcinoma.
Abulaban A; Yanchenko N; Briski LM; Punnen S; Jorda M; Kryvenko ON
Arch Pathol Lab Med; 2023 Dec; ():. PubMed ID: 38133938
[TBL] [Abstract][Full Text] [Related]
12. pT1 high-grade bladder cancer: histologic criteria, pitfalls in the assessment of invasion, and substaging.
Raspollini MR; Montironi R; Mazzucchelli R; Cimadamore A; Cheng L; Lopez-Beltran A
Virchows Arch; 2020 Jul; 477(1):3-16. PubMed ID: 32296929
[TBL] [Abstract][Full Text] [Related]
13. News in the classification of WHO 2022 bladder tumors.
Raspollini MR; Comperat EM; Lopez-Beltran A; Montironi R; Cimadamore A; Tsuzuki T; Netto GJ
Pathologica; 2022 Feb; 115(1):32-40. PubMed ID: 36704871
[TBL] [Abstract][Full Text] [Related]
14. An update on computational pathology tools for genitourinary pathology practice: A review paper from the Genitourinary Pathology Society (GUPS).
Parwani AV; Patel A; Zhou M; Cheville JC; Tizhoosh H; Humphrey P; Reuter VE; True LD
J Pathol Inform; 2023; 14():100177. PubMed ID: 36654741
[TBL] [Abstract][Full Text] [Related]
15. Bladder Cancer Sample Handling and Reporting: Pathologist's Point of View.
Mazzucchelli R; Marzioni D; Tossetta G; Pepi L; Montironi R
Front Surg; 2021; 8():754741. PubMed ID: 34926567
[TBL] [Abstract][Full Text] [Related]
16. Recent Advances in the Management of Patients with Non-Muscle-Invasive Bladder Cancer Using a Multidisciplinary Approach: Practical Recommendations from the Spanish Oncology Genitourinary (SOGUG) Working Group.
Rubio-Briones J; Algaba F; Gallardo E; Marcos-Rodríguez JA; Climent MÁ; On Behalf Of The Sogug Multidisciplinary Working Group
Cancers (Basel); 2021 Sep; 13(19):. PubMed ID: 34638247
[TBL] [Abstract][Full Text] [Related]
17. Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression.
Lawless M; Gulati R; Tretiakova M
Histopathology; 2017 Sep; 71(3):406-414. PubMed ID: 28470753
[TBL] [Abstract][Full Text] [Related]
18. Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series.
Bertz S; Denzinger S; Otto W; Wieland WF; Stoehr R; Hofstaedter F; Hartmann A
Histopathology; 2011 Oct; 59(4):722-32. PubMed ID: 22014053
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
